Precision Cancer Medicine

Overview

The Precision Cancer Medicine programme at the University of Oxford will appeal to health professionals from a variety of backgrounds including clinical academics, diagnosticians, scientists and clinicians from academia and industry; bio-informaticians, statisticians and scientists and clinicians working in all stages of target discovery and drug development.

Precision medicine is an emerging approach which takes into account variability in the biology, environment, and lifestyle for each individual person to help guide disease diagnosis and treatment. In particular, genetic and genomic data allow us to go beyond conventional histopathological assessment, and classify cancer into distinct sub-entities, leading to novel molecularly-directed treatment approaches.

Supervision

You will be assigned a personal advisor from the course team, who will help you review your progress, and discuss any concerns you have; your course advisor and the course administration team will usually be your first port of call for any queries about your studies. You will also have an advisor at your Oxford college, whose support you can seek for issues you choose not to discuss with the course team.  During the research project you will be allocated a project supervisor who will be responsible for your supervision and training. 

The allocation of graduate supervision is the responsibility of the Department of Oncology and it is not always possible to accommodate the preferences of incoming graduate students to work with a particular member of staff. A supervisor may be found outside the Department of Oncology. 

Graduate destinations

This is a new course, with the first cohort due to start in October 2020. It is expected that graduates will hold senior positions in a variety of roles, as clinical academics, diagnosticians, scientists and clinicians in academia, health services and the pharmaceutical industry.